c.i. 42510 has been researched along with pyridoxal phosphate in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hibell, AD; Humphrey, PP; Michel, AD; Thompson, KM; Xing, M | 1 |
| Eschke, D; Hauschildt, S; Nieber, K; Wüst, M | 1 |
| Gerstberger, R; Gourine, AV; Gourine, VN; Melenchuk, EV; Poputnikov, DM; Spyer, KM; Zhernosek, N | 1 |
| Humphrey, PP; Jones, CA; Michel, AD; Thompson, KM; Xing, M | 1 |
| Han, Z; Taylor, JM | 1 |
| Bramlett, HM; Dietrich, WD; Frydel, B; Marcillo, A | 1 |
| Franke, H; Grohmann, M; Illes, P; Kunert, C; Messemer, N; Nieber, K; Nörenberg, W; Riedel, T; Rubini, P; Schaefer, M; Sobottka, H; Straub, I; Zimmermann, H | 1 |
| Benz, R; Bumba, L; Fiser, R; Hewlett, EL; Linhartova, I; Masin, J; Osicka, R; Sebo, P | 1 |
| Almeida, FM; de Andrade, GM; Marques, SA; Martinez, AMB; Melo, PA; Oliveira, JT; Ribeiro, T; Tomaz, MA | 1 |
| Adhikary, SR; Casolin, S; Cuthbertson, P; Geraghty, NJ; Sluyter, R; Watson, D | 1 |
10 other study(ies) available for c.i. 42510 and pyridoxal phosphate
| Article | Year |
|---|---|
Complexities of measuring antagonist potency at P2X(7) receptor orthologs.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenosine Triphosphate; Amiloride; Animals; Benzoxazoles; Buffers; Cations, Divalent; Cell Adhesion; Cells, Cultured; Drug Interactions; Enzyme Inhibitors; Ethidium; Fluorescent Dyes; Humans; Kinetics; Mice; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Quinolinium Compounds; Rats; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Rosaniline Dyes; Serum Albumin, Bovine; Sodium Chloride; Species Specificity; Temperature | 2001 |
Pharmacological characterization of the P2X(7) receptor on human macrophages using the patch-clamp technique.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenosine Triphosphate; Cells, Cultured; Electrophysiology; Humans; Macrophages; Monocytes; Patch-Clamp Techniques; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Rosaniline Dyes | 2002 |
P2 receptor blockade attenuates fever and cytokine responses induced by lipopolysaccharide in rats.
Topics: Animals; Body Temperature; Fever; Interleukin-1; Interleukin-6; Lipopolysaccharides; Male; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Rats; Rats, Wistar; Receptors, Purinergic P2X7; Rosaniline Dyes; Suramin; Tumor Necrosis Factor-alpha | 2005 |
Decavanadate, a P2X receptor antagonist, and its use to study ligand interactions with P2X7 receptors.
Topics: Calcium Signaling; Cell Line; Dose-Response Relationship, Drug; Humans; Kinetics; Ligands; Membrane Potentials; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Receptors, Purinergic P2; Receptors, Purinergic P2X2; Receptors, Purinergic P2X4; Receptors, Purinergic P2X7; Rosaniline Dyes; Transfection; Vanadates | 2006 |
Purinergic receptor functionality is necessary for infection of human hepatocytes by hepatitis delta virus and hepatitis B virus.
Topics: Animals; Cell Line; Hepatitis B virus; Hepatitis Delta Virus; Hepatocytes; Humans; Inflammation; Pyridoxal Phosphate; Rats; Receptors, Purinergic; Receptors, Purinergic P2X7; RNA, Viral; Rosaniline Dyes; Suramin | 2010 |
A reassessment of P2X7 receptor inhibition as a neuroprotective strategy in rat models of contusion injury.
Topics: Animals; Contusions; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Neuroprotective Agents; Purinergic P2X Receptor Antagonists; Pyridoxal Phosphate; Rats; Rats, Inbred F344; Rats, Sprague-Dawley; Receptors, Purinergic P2X7; Rosaniline Dyes; Spinal Cord Injuries | 2012 |
P2X7 receptors at adult neural progenitor cells of the mouse subventricular zone.
Topics: Adenosine Triphosphate; Animals; Benzoxazoles; Calcium; Caspase 3; Cell Survival; Dose-Response Relationship, Drug; Lateral Ventricles; Membrane Potentials; Mice; Mice, Knockout; Primary Cell Culture; Purinergic P2X Receptor Agonists; Purinergic P2X Receptor Antagonists; Pyridines; Pyridoxal Phosphate; Quinolinium Compounds; Receptors, Purinergic P2X7; Rosaniline Dyes; Stem Cells; Tetrazoles | 2013 |
Differences in purinergic amplification of osmotic cell lysis by the pore-forming RTX toxins Bordetella pertussis CyaA and Actinobacillus pleuropneumoniae ApxIA: the role of pore size.
Topics: Actinobacillus pleuropneumoniae; Adenylate Cyclase Toxin; Animals; Bacterial Proteins; Bordetella pertussis; Cell Membrane; Cell Membrane Permeability; Cells, Cultured; Erythrocytes; Hemolysin Proteins; Hemolysis; Hexokinase; Lipid Bilayers; Macrophages; Mice; Osmotic Pressure; Pyridoxal Phosphate; Rosaniline Dyes | 2013 |
Blockade of ATP P2X7 receptor enhances ischiatic nerve regeneration in mice following a crush injury.
Topics: Analgesics; Animals; Crush Injuries; Disease Models, Animal; Female; Ganglia, Spinal; Hyperalgesia; Interleukin-1alpha; Mice, Inbred C57BL; Motor Activity; Nerve Regeneration; Neuroprotective Agents; Peripheral Nerve Injuries; Peripheral Nerves; Purinergic P2X Receptor Antagonists; Pyridoxal Phosphate; Random Allocation; Receptors, Purinergic P2X7; Rosaniline Dyes; Spinal Cord; Tumor Necrosis Factor-alpha | 2017 |
P2X7 receptor antagonism increases regulatory T cells and reduces clinical and histological graft-versus-host disease in a humanised mouse model.
Topics: Adult; Animals; B-Lymphocytes; Disease Models, Animal; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukocytes, Mononuclear; Male; Mice, Inbred NOD; Mice, SCID; Purinergic P2X Receptor Antagonists; Pyridoxal Phosphate; Receptors, Purinergic P2X7; Rosaniline Dyes; T-Lymphocytes, Regulatory | 2021 |